Distinct prognostic values of alcohol dehydrogenase mRNA expression in pancreatic adenocarcinoma

References

• KamisawaTWoodLDItoiTTakaoriKPancreatic cancerLancet201638810039738526830752
   PubMed Web of Science ®Google Scholar
• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
   PubMed Web of Science ®Google Scholar
• ZengHZhengRGuoYCancer survival in China, 2003–2005: a population-based studyInt J Cancer201513681921193025242378
   PubMed Web of Science ®Google Scholar
• HaberPSApteMVApplegateTLMetabolism of ethanol by rat pancreatic acinar cellsJ Lab Clin Med199813242943029794700
   PubMedGoogle Scholar
• ChrostekLJelskiWSzmitkowskiMPuchalskiZAlcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) activity in the human pancreasDig Dis Sci20034871230123312870777
   PubMedGoogle Scholar
• JelskiWChrostekLSzmitkowskiMThe activity of class I, II, III, and IV of alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in pancreatic cancerPancreas200735214214617632320
   PubMed Web of Science ®Google Scholar
• JelskiWKutylowskaELaniewska-DunajMSzmitkowskiMAlcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) as candidates for tumor markers in patients with pancreatic cancerJ Gastrointestin Liver Dis201120325525921961092
   PubMed Web of Science ®Google Scholar
• MohamedAASolimanHIsmailMEvaluation of circulating ADH and MIC-1 as diagnostic markers in Egyptian patients with pancreatic cancerPancreatology2015151343925464937
   PubMedGoogle Scholar
• AndersSHuberWDifferential expression analysis for sequence count dataGenome Biol20101110R10620979621
   PubMed Web of Science ®Google Scholar
• ShaulYDYuanBThiruPMERAV: a tool for comparing gene expression across human tissues and cell typesNucleic Acids Res201644D1D560D56626626150
   PubMed Web of Science ®Google Scholar
• SubramanianATamayoPMoothaVKGene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profilesProc Natl Acad Sci U S A200510243155451555016199517
   PubMed Web of Science ®Google Scholar
• MoothaVKLindgrenCMErikssonKFPGC-1alpha-responsive genes involved in oxidative phosphorylation is coordinately downregulated in human diabetesNat Genet200334326727312808457
   PubMed Web of Science ®Google Scholar
• ReinerAYekutieliDBenjaminiYIdentifying differentially expressed genes using false discovery rate controlling proceduresBioinformatics200319336837512584122
   PubMed Web of Science ®Google Scholar
• BenjaminiYHochbergYControlling the false discovery rate: a practical and powerful approach to multiple testingJ R Stat Soc Series B Stat Methodol1995571289300
   Web of Science ®Google Scholar
• KlyosovAAKinetics and specificity of human liver aldehyde dehydrogenases toward aliphatic, aromatic, and fused polycyclic aldehydesBiochemistry19963514445744678605195
   PubMed Web of Science ®Google Scholar
• OrywalKSzmitkowskiMAlcohol dehydrogenase and aldehyde dehydrogenase in malignant neoplasmsClin Exp Med201717213113926886278
   PubMedGoogle Scholar
• HolmesRSAlcohol dehydrogenases: a family of isozymes with differential functionsAlcohol Alcohol Suppl199421271308974326
   PubMedGoogle Scholar
• JelskiWSzmitkowskiMAlcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) in the cancer diseasesClin Chim Acta20083951–21518505683
   PubMed Web of Science ®Google Scholar
• OrywalKJelskiWWerelTSzmitkowskiMThe diagnostic significance of serum alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase activity in renal cell cancer patientsExp Mol Pathol2016100341642027086037
   PubMedGoogle Scholar
• JelskiWLaniewska-DunajMOrywalKKochanowiczJRutkowskiRSzmitkowskiMThe diagnostic value of alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) measurement in the sera of patients with brain tumorArch Med Sci201713234635228261287
   PubMedGoogle Scholar
• JelskiWMroczkoBSzmitkowskiMThe diagnostic value of alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) measurement in the sera of colorectal cancer patientsDig Dis Sci201055102953295720069455
   PubMedGoogle Scholar
• OrywalKJelskiWZdrodowskiMSzmitkowskiMThe diagnostic value of alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase measurement in the sera of patients with endometrial cancerAnticancer Res20133393725373024023302
   PubMed Web of Science ®Google Scholar
• OrywalKJelskiWZdrodowskiMSzmitkowskiMThe diagnostic value of alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase measurement sera of cervical cancer patientsAnticancer Res20163652265226927127132
   PubMedGoogle Scholar
• JelskiWLaniewska-DunajMNiklinskiJKozlowskiMLaudanskiJSzmitkowskiMThe alcohol dehydrogenase isoenzyme (ADH IV) as a candidate tumour marker of esophageal cancerActa Biochim Polonica2013603489493
   PubMedGoogle Scholar
• JelskiWOrywalKLaniewskaMSzmitkowskiMThe diagnostic value of alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) measurement in the sera of gastric cancer patientsClin Exp Med201010421521920454995
   PubMed Web of Science ®Google Scholar
• JelskiWZalewskiBSzmitkowskiMAlcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) activity in the sera of patients with liver cancerJ Clin Lab Anal200822320420918484658
   PubMed Web of Science ®Google Scholar
• JelskiWZalewskiBSzmitkowskiMThe activity of class I, II, III, and IV alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) in liver cancerDig Dis Sci20085392550255518224440
   PubMedGoogle Scholar
• JelskiWZalewskiBChrostekLSzmitkowskiMAlcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) activity in the sera of patients with colorectal cancerClin Expl Med200774154157
   PubMedGoogle Scholar
• JelskiWZalewskiBChrostekLSzmitkowskiMThe activity of class I, II, III, and IV alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in colorectal cancerDig Dis Sci200449697798115309886
   PubMedGoogle Scholar
• JelskiWLaniewska-DunajMOrywalKKochanowiczJRutkowskiRSzmitkowskiMThe activity of alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) in the sera of patients with brain cancerNeurochem Res201439122313231825300996
   PubMedGoogle Scholar
• Laniewska-DunajMJelskiWOrywalKKochanowiczJRutkowskiRSzmitkowskiMThe activity of class I, II, III and IV of alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) in brain cancerNeurochem Res20133871517152123624825
   PubMedGoogle Scholar
• OrywalKJelskiWZdrodowskiMSzmitkowskiMThe activity of class I, II, III and IV alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in cervical cancerClin Biochem20114414–151231123421784063
   PubMedGoogle Scholar
• OrywalKJelskiWZdrodowskiMSzmitkowskiMThe activity of class I, II, III and IV alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in ovarian cancer and ovarian cystsAdv Med Sci201358221622024327532
   PubMedGoogle Scholar
• OrywalKJelskiWZdrodowskiMSzmitkowskiMThe activity of class I, II, III, and IV alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in endometrial cancerJ Clin Lab Anal201024533433920872569
   PubMedGoogle Scholar
• OrywalKJelskiWWerelTSzmitkowskiMThe activity of class I, II, III and IV alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in renal cell carcinomaExp Mol Pathol201598340340625779850
   PubMedGoogle Scholar
• OrywalKJelskiWWerelTSzmitkowskiMThe activity of class I, II, III and IV alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in the sera of bladder cancer patientsActa Biochim Polonica20176418184
   PubMedGoogle Scholar
• JelskiWKozlowskiMLaudanskiJNiklinskiJSzmitkowskiMAlcohol dehydrogenase isoenzymes and aldehyde dehydrogenase activity in the sera of patients with esophageal cancerClin Exp Med20099213113719184326
   PubMedGoogle Scholar
• JelskiWChrostekLSzmitkowskiMMarkiewiczWThe activity of class I, II, III and IV alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in breast cancerClin Exp Med200662899316820997
   PubMedGoogle Scholar
• JelskiWKozlowskiMLaudanskiJNiklinskiJSzmitkowskiMThe activity of class I, II, III, and IV alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) in esophageal cancerDig Dis Sci200954472573018688716
   PubMedGoogle Scholar
• BongaertsBWde GoeijAFWoutersKAAlcohol consumption, alcohol dehydrogenase 1C (ADH1C) genotype, and risk of colorectal cancer in the Netherlands Cohort Study on diet and cancerAlcohol201145321722521163612
   PubMedGoogle Scholar
• BrocicMSupicGZeljicKGenetic polymorphisms of ADH1C and CYP2E1 and risk of oral squamous cell carcinomaOtolaryngol Head Neck Surg2011145458659321705789
   PubMedGoogle Scholar
• SolomonPRSelvamGSShanmugamGPolymorphism in ADH and MTHFR genes in oral squamous cell carcinoma of IndiansOral Dis200814763363918266839
   PubMed Web of Science ®Google Scholar
• van DijkBvan HouwelingenKPWitjesJASchalkenJAKiemeneyLAAlcohol dehydrogenase type 3 (ADH3) and the risk of bladder cancerEur Urol200140550951411752857
   PubMedGoogle Scholar
• McKayJDTruongTGaborieauVA genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortiumPLoS Genet201173e100133321437268
   PubMedGoogle Scholar
• OzeIMatsuoKSuzukiTImpact of multiple alcohol dehydrogenase gene polymorphisms on risk of upper aerodigestive tract cancers in a Japanese populationCancer Epidemiol Biomarkers Prev200918113097310219861527
   PubMedGoogle Scholar
• JiYBLeeSHKimKRAssociation between ADH1B and ADH1C polymorphisms and the risk of head and neck squamous cell carcinomaTumour Biol20153664387439625874489
   PubMedGoogle Scholar
• TerryMBGammonMDZhangFFAlcohol dehydrogenase 3 and risk of esophageal and gastric adenocarcinomasCancer Causes Control20071891039104617665311
   PubMedGoogle Scholar
• HidakaASasazukiSMatsuoKJPHC Study GroupGenetic polymorphisms of ADH1B, ADH1C and ALDH2, alcohol consumption, and the risk of gastric cancer: the Japan Public Health Center-based prospective studyCarcinogenesis201536222323125524923
   PubMed Web of Science ®Google Scholar
• WeiRRZhangMYRaoHLPuHYZhangHZWangHYIdentification of ADH4 as a novel and potential prognostic marker in hepatocellular carcinomaMed Oncol20122942737274322147505
   PubMedGoogle Scholar
• ShangLZhuGSuHIdentification of alcohol dehydrogenase as a potential prognostic marker in HBV-related hepatocellular carcinomaInt J Clin Exp Med201710344574472
   Google Scholar
• NebertDWRussellDWClinical importance of the cytochromes P450Lancet200236093401155116212387968
   PubMed Web of Science ®Google Scholar
• Rodriguez-AntonaCIngelman-SundbergMCytochrome P450 pharmacogenetics and cancerOncogene200625111679169116550168
   PubMed Web of Science ®Google Scholar
• HlavatyJPetznekHHolzmullerHEvaluation of a gene-directed enzyme-product therapy (GDEPT) in human pancreatic tumor cells and their use as in vivo models for pancreatic cancerPLoS One201277e4061122815775
   PubMedGoogle Scholar
• LiuSXXiaZSZhongYQGene therapy in pancreatic cancerWorld journal of gastroenterology20142037133431336825309069
   PubMedGoogle Scholar
• GandhiAVSaxenaSRellesDDifferential expression of cytochrome P450 omega-hydroxylase isoforms and their association with clinicopathological features in pancreatic ductal adenocarcinomaAnn Surg Oncol201320Suppl 3S636S64323846787
   PubMedGoogle Scholar
• FriessHYamanakaYBuchlerMEnhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survivalGastroenterology19931056184618568253361
   PubMed Web of Science ®Google Scholar
• GlazerESWelshEPimientoJMTeerJKMalafaMPTGFbeta1 overexpression is associated with improved survival and low tumor cell proliferation in patients with early-stage pancreatic ductal adenocarcinomaOncotarget201781999100627895310
   PubMedGoogle Scholar
• CravenKEGoreJWilsonJLKorcMAngiogenic gene signature in human pancreatic cancer correlates with TGF-beta and inflammatory transcriptomesOncotarget20167132334126586478
   PubMedGoogle Scholar
• JavleMLiYTanDBiomarkers of TGF-beta signaling pathway and prognosis of pancreatic cancerPLoS One201491e8594224465802
   PubMed Web of Science ®Google Scholar
• GasparNJLiLKapounAMInhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasivenessMol Pharmacol200772115216117400764
   PubMedGoogle Scholar
• SanoMDriscollDRDeJesus-MongeWEActivation of WNT/beta-catenin signaling enhances pancreatic cancer development and the malignant potential via up-regulation of Cyr61Neoplasia2016181278579427889647
   PubMedGoogle Scholar
• ZhouWLiYGouSMiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/beta-catenin pathwayOncotarget2015635375573756926485754
   PubMedGoogle Scholar
• JiangHLiQHeCActivation of the Wnt pathway through Wnt2 promotes metastasis in pancreatic cancerAm J Cancer Res20144553754425232495
   PubMed Web of Science ®Google Scholar
• ThomasGChardesTGaboritNHER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical modelsOncotarget20145167138714825216528
   PubMed Web of Science ®Google Scholar
• TroianiTMartinelliECapassoATargeting EGFR in pancreatic cancer treatmentCurr Drug Targets201213680281022458527
   PubMed Web of Science ®Google Scholar
• MiyabayashiKIjichiHMohriDErlotinib prolongs survival in pancreatic cancer by blocking gemcitabine-induced MAPK signalsCancer Res20137372221223423378339
   PubMedGoogle Scholar
• KoizumiKTannoSNakanoYActivation of p38 mitogen-activated protein kinase is necessary for gemcitabine-induced cytotoxicity in human pancreatic cancer cellsAnticancer Res20052553347335316101149
   PubMedGoogle Scholar